27. März 2025

ÜBER DIESE EPISODE

Rethinking Risk Management w. Doug Hubbard

In this episode of Inside MedTech Innovation, I sit down with Doug Hubbard, the decision science expert behind How to Measure Anything and The Failure of Risk Management. Together, we unpack the hidden flaws in how MedTech organizations assess uncertainty—and how to fix them with data-driven models.

00:22 Meet the Expert: Doug Hubbard

01:25 The Importance of Data-Driven Decision Science

03:01 Challenges in Risk Management

04:44 Doug Hubbard's Journey and Career

22:53 Applied Information Economics Explained

44:59 Understanding Clinical Trial Evidence

45:18 The Analysis Placebo Effect

47:21 The Psychology of Risk Scoring

48:47 Partition Dependence and Illusion of Agreement

52:30 Quantitative Methods in Risk Management

59:04 Practical Steps to Improve Risk Assessment

01:13:34 Addressing Third-Party Risks

01:21:57 Regulating Medical AI

01:27:07 Conclusion and Final Thoughts

Follow Shannon and Doug:

Connect with Shannon:

LinkedIn: https://www.linkedin.com/in/shannonlantzy

Website: https://www.shannonlantzy.com

Connect with Doug:

LinkedIn: https://www.linkedin.com/in/dwhubbard/

Website: https://hubbardresearch.com/

Technologie

Englisch

Vereinigte Staaten

Verwenden SieAPI, um diese Episode inJSONabzurufen

IN DIESER FOLGE

# doug hubbard

Diese Tags bearbeiten

TRANSKRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Inside MedTech Innovation durchsuchen.

Betten Sie diese Suchleiste in Ihre Website ein

WEITERE EPISODEN IN DIESEM PODCAST

Marketing MedTech w. Joy Duemke

12. Februar 2026

Only 2% of sickle cell patients who could benefit from blood therapy actually receive it, despite it being first-line treatment. Marketing in medical devices isn't about jingles or promotions. It's about looking at data, drawing hypotheses, testing them, and ensuring every claim you make is scienti…

00:46:45

SPEICHERN

Clip

Bridging Diabetes Tech w. Dr. Bob Gabbay

12. März 2026

Dr. Bob Gabbay has spent decades at the intersection of diabetes research, clinical care, and technology innovation. From leading the Joslin Diabetes Center to serving as Chief Scientific and Medical Officer at the American Diabetes Association, he witnessed the field transform from sharpening need…

01:02:23

SPEICHERN

Clip

Behind FDA’s Heroes w. Dr. Robert Califf

16. April 2026

FDA commissioners come and go, but career civil servants are always there, applying the rules without financial conflicts of interest. Dr. Robert Califf served as FDA Commissioner twice, making him one of the most experienced regulatory leaders in healthcare history. Before FDA, he built the world'…

00:36:40

SPEICHERN

Clip

Tech For MedTech: Automated Compliance w. Michael Edenzon

26. Februar 2026

One medical device company cut their software recall response time from 180 days to under 30 by automating compliance evidence collection. In regulated industries like MedTech, shipping software takes weeks not because the code isn't ready, but because proving compliance requires manual evidence ga…

00:57:47

SPEICHERN

Clip

Biodesign for MedTech w. Josh Makower

26. März 2026

The Stanford Mussallem Center for Biodesign has trained innovators whose inventions have touched over 18 million lives while they were still in training. Most people think breakthrough innovation is magic or unpredictable. Dr. Josh Makower proved otherwise. As co-founder of the Stanford Mussallem C…

01:03:16

SPEICHERN

Clip

Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Shannon Lantzy, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.